Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?

Tenaya Therapeutics Ownership Summary

Tenaya Therapeutics is owned by 21.19% institutional investors, 0.69% insiders, and 78.12% retail investors. Column group is the largest institutional shareholder, holding 5.77% of TNYA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 2.66% of its assets in Tenaya Therapeutics shares.

TNYA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenaya Therapeutics	21.19%	0.69%	78.12%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Column group	9.40M	5.77%	$14.85M
Blackrock	4.07M	5.03%	$12.63M
Vanguard group	5.06M	3.11%	$8.21M
Ghost tree capital	1.35M	1.67%	$4.18M
Blackrock funding, inc. /de	2.33M	1.43%	$3.77M
Renaissance	1.68M	1.03%	$2.72M
Geode capital management	1.18M	0.72%	$1.91M
Euclidean capital	1.02M	0.62%	$1.65M
Alphabet	915.71K	0.56%	$1.48M
Two sigma investments, lp	910.57K	0.56%	$1.48M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Column group	9.40M	18.35%	$14.85M
Ghost tree capital	1.35M	1.31%	$4.18M
Euclidean capital	1.02M	0.69%	$1.65M
Stepstone group lp	462.16K	0.35%	$748.70K
Diadema partners lp	315.52K	0.13%	$511.14K
Persistent asset partners	72.49K	0.08%	$117.44K
Trustees of columbia university in the city of new york	291.83K	0.07%	$472.76K
Gsa capital partners llp	461.80K	0.06%	$748.00K
Alphabet	915.71K	0.06%	$1.48M
Casdin capital	361.97K	0.05%	$586.39K

Top Buyers

Holder	Shares	% Assets	Change
Ghost tree capital	1.35M	1.31%	575.00K
Schonfeld strategic advisors	465.96K	0.00%	465.96K
Gsa capital partners llp	461.80K	0.06%	461.80K
Two sigma investments, lp	910.57K	0.00%	435.78K
Raiffeisen bank	350.00K	0.01%	350.00K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.98M
Woodline partners lp	-	-	-5.92M
Octagon capital advisors lp	-	-	-2.58M
Integral health asset management	-	-	-2.38M
Vr adviser	-	-	-1.56M

New Positions

Holder	Shares	% Assets	Change	Value
Schonfeld strategic advisors	465.96K	0.00%	465.96K	$754.85K
Gsa capital partners llp	461.80K	0.06%	461.80K	$748.00K
Raiffeisen bank	350.00K	0.01%	350.00K	$553.00K
Diadema partners lp	315.52K	0.13%	315.52K	$511.14K
Xtx topco	97.84K	0.01%	97.84K	$158.50K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-11.00
Capital performance advisors llp	-12.00
Clearstead advisors	-82.00
Rise advisors	-485.00
Smartleaf asset management	-612.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	91	-	34,496,870	9.27%	21	5.63%	34	-24.44%	31	29.17%
Jun 30, 2025	91	-14.95%	31,571,278	-34.46%	19	1.01%	44	-16.98%	25	-21.88%
Mar 31, 2025	2	-97.70%	32,748	-99.92%	-	0.00%	1	-97.92%	1	-94.74%
Dec 31, 2024	49	-47.31%	18,984,954	-67.06%	22	0.49%	29	-43.14%	9	-47.06%
Sep 30, 2024	93	-3.13%	57,630,897	1.33%	66	1.36%	51	-5.56%	17	-37.04%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
US Small-Cap Growth II Equity Comp	2.10M	2.66%	-471.71K
T. Rowe Price New Horizons	2.10M	2.65%	-441.00
Fidelity Select Biotechnology	1.75M	2.20%	-
Vanguard Total Stock Mkt Idx Inv	2.82M	1.73%	-62.29K
JPMorgan US Small Company L	785.69K	0.91%	-315.70K
Vanguard Institutional Extnd Mkt Idx Tr	1.23M	0.76%	-562.30K
T. Rowe Price New Horizons Tr-Z	554.73K	0.70%	9.11K
Fidelity Small Cap Index	608.02K	0.37%	-
abrdn Life Sciences Investors	600.70K	0.37%	-
BlackRock Health Sciences Term Trust	291.39K	0.37%	-120.40K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 17, 2025	Higa Tomohiro	SVP, Finance	Sell	$1.82K
Nov 17, 2025	Tingley Whittemore	Chief Medical Officer	Sell	$3.83K
Nov 17, 2025	Ali Faraz	Chief Executive Officer	Sell	$4.16K
Aug 18, 2025	Higa Tomohiro	SVP, Finance	Sell	$2.16K
Aug 18, 2025	Higa Tomohiro	SVP, Finance	Sell	$655.32

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	3
2025 Q3	-	9
2025 Q2	-	3
2025 Q1	6	8
2024 Q4	-	1

TNYA Ownership FAQ

Who Owns Tenaya Therapeutics?

Tenaya Therapeutics shareholders are primarily institutional investors at 21.19%, followed by 0.69% insiders and 78.12% retail investors. The average institutional ownership in Tenaya Therapeutics's industry, Biotech Stocks , is 45.22%, which Tenaya Therapeutics falls below.

Who owns the most shares of Tenaya Therapeutics?

Tenaya Therapeutics’s largest shareholders are Column group (9.4M shares, 5.77%), Blackrock (4.07M shares, 5.03%), and Vanguard group (5.06M shares, 3.11%). Together, they hold 13.92% of Tenaya Therapeutics’s total shares outstanding.

Does Blackrock own Tenaya Therapeutics?

Yes, BlackRock owns 5.03% of Tenaya Therapeutics, totaling 4.07M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 12.63M$. In the last quarter, BlackRock decreased its holdings by -627K shares, a -13.34% change.

Who is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is Tenaya Therapeutics’s biggest shareholder by percentage of total assets invested, with 18.35% of its assets in 9.4M Tenaya Therapeutics shares, valued at 14.85M$.

Who is the top mutual fund holder of Tenaya Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Tenaya Therapeutics shares, with 2.66% of its total shares outstanding invested in 2.1M Tenaya Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools